These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Subscribe To Our Newsletter & Stay Updated
